China Universal Asset Management Co., Ltd.
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1906594
SHANGHAI, F4
Position in INDV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$676,473
New position
Shares Held
22,194
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026China Universal Asset Management Co., Ltd. holds $16,253,141 across 28 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
7,778 | $4,612,198 | |
| 2 | VTRS |
Viatris Inc
|
204,324 | $2,760,417 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
17,810 | $2,346,289 | |
| 4 | ALKS |
Alkermes plc.
|
29,573 | $1,045,701 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
55,834 | $694,016 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
22,194 | $676,473 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
10,175 | $525,945 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
44,507 | $423,706 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $676,473 | 22,194 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||